News & Updates

Preventing respiratory syncytial virus (RSV) in infants can be achieved through maternal vaccination with the RSV prefusion F protein (RSVpreF) vaccine or administration of the monoclonal antibody nirsevimab—strategies endorsed by the WHO. In a French population-based cohort study, nirsevimab has been associated with lower risks of RSV-related hospitalizations and severe outcomes.

Treatment with REP 2139-Mg (REP), a nucleic acid polymer, demonstrates efficacy and an acceptable safety profile among patients with hepatitis D virus (HDV) and advanced chronic liver disease (CLD), reports a recent study.

Immunization against the human papillomavirus (HPV) can reduce the incidence of various cancer types in females 9 to 26 years of age, according to a study.

Valacyclovir appears to have little benefit in the treatment of individuals with early symptomatic Alzheimer’s disease (AD) and herpes simplex virus (HSV) seropositivity, according to the results of the phase II VALAD study.

Adjunctive Rose Bengal (RB) photodynamic therapy (PDT) shows no benefit in the treatment of fungal, Acanthemoeba, and smear- or culture-negative infectious keratitis, according to a study.

Anticholinergic burden (ACB) is significantly associated with sleep disorders among people living with HIV, according to a study.